Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 Study of AJH-2947 in Healthy Male Subjects
NCT06155487Phase 1Completed
- Sponsor
- JMackem Co., Ltd.
- Start
- Dec 2023
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of AJH-2947 in chronic pain syndrome (CPS), sponsored by JMackem Co., Ltd. Primary endpoints: Maximum observed plasma concentration, Area under the concentration-time curve to the last quantifiable concentration and 6 more. Started Dec 2023; status: completed.
02
Drugs
AJH-2947
03
Conditions
chronic pain syndrome (CPS)
Beyond the preview
Go deeper on NCT06155487.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06155487.